1. Home
  2. DXCM vs ACGL Comparison

DXCM vs ACGL Comparison

Compare DXCM & ACGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DXCM
  • ACGL
  • Stock Information
  • Founded
  • DXCM 1999
  • ACGL 2001
  • Country
  • DXCM United States
  • ACGL Bermuda
  • Employees
  • DXCM N/A
  • ACGL N/A
  • Industry
  • DXCM Medical/Dental Instruments
  • ACGL Property-Casualty Insurers
  • Sector
  • DXCM Health Care
  • ACGL Finance
  • Exchange
  • DXCM Nasdaq
  • ACGL Nasdaq
  • Market Cap
  • DXCM 31.7B
  • ACGL 34.5B
  • IPO Year
  • DXCM 2005
  • ACGL 1995
  • Fundamental
  • Price
  • DXCM $76.44
  • ACGL $87.35
  • Analyst Decision
  • DXCM Strong Buy
  • ACGL Buy
  • Analyst Count
  • DXCM 19
  • ACGL 15
  • Target Price
  • DXCM $99.89
  • ACGL $112.21
  • AVG Volume (30 Days)
  • DXCM 4.5M
  • ACGL 1.8M
  • Earning Date
  • DXCM 10-23-2025
  • ACGL 10-29-2025
  • Dividend Yield
  • DXCM N/A
  • ACGL 5.73%
  • EPS Growth
  • DXCM N/A
  • ACGL N/A
  • EPS
  • DXCM 1.43
  • ACGL 9.67
  • Revenue
  • DXCM $4,300,800,000.00
  • ACGL $19,156,000,000.00
  • Revenue This Year
  • DXCM $17.03
  • ACGL $3.34
  • Revenue Next Year
  • DXCM $15.59
  • ACGL $5.81
  • P/E Ratio
  • DXCM $53.42
  • ACGL $9.03
  • Revenue Growth
  • DXCM 9.30
  • ACGL 23.80
  • 52 Week Low
  • DXCM $57.52
  • ACGL $82.49
  • 52 Week High
  • DXCM $93.25
  • ACGL $116.47
  • Technical
  • Relative Strength Index (RSI)
  • DXCM 44.18
  • ACGL 38.46
  • Support Level
  • DXCM $75.39
  • ACGL $88.70
  • Resistance Level
  • DXCM $78.96
  • ACGL $92.93
  • Average True Range (ATR)
  • DXCM 2.36
  • ACGL 1.67
  • MACD
  • DXCM 0.01
  • ACGL -0.54
  • Stochastic Oscillator
  • DXCM 36.35
  • ACGL 3.59

About DXCM DexCom Inc.

DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.

About ACGL Arch Capital Group Ltd.

Arch Capital Group Ltd is a Bermuda company that writes insurance and reinsurance with operations in the United States, Canada, Europe, Australia, and the United Kingdom. The business operates through three underwriting segments: insurance, reinsurance, and mortgage. The insurance segment provides specialty risk solutions to clients across various industries. The reinsurance segment provides reinsurance services which cover property catastrophe, property, liability, marine, aviation and space, trade credit and surety, agriculture, accident, life and health, and political risk. The mortgage business provides risk management and risk financing products to the mortgage insurance sectors through platforms in the U.S., Europe and Bermuda.

Share on Social Networks: